This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsbluebird biobluebird bio Funding Rounds, Valuation & Investors
bluebird bio company logo
bluebird bio
We believe we can unlock the potential for fuller, healthier lives501-1000 Employees
View 0 jobs

bluebird bio Funding

$138.5M
55 rounds
bluebird bio is active in the following markets / industries: biotechnology, pharmaceuticals, diagnostics and genetic testing. The company has secured funding across 5 rounds, totaling in an amount of $138.5M. Their most recent funding was raised on October 27, 2012.

Funding Rounds

U
$9300000
UnknownOct 2012
Avatar for California Institute for Regenerative Medicine
D
$60000000
Series DJul 2012
Avatar for TVM Capital
Avatar for Forbion Capital Partners
Avatar for ARCH Venture Partners
Avatar for Third Rock Ventures
+2
U
$30000000
UnknownApr 2011
Avatar for ARCH Venture Partners
Avatar for Forbion Capital Partners
Avatar for TVM Capital
+1
U
$4200000
UnknownMar 2011
B
$35000000
Series BMar 2010
Avatar for Third Rock Ventures
Avatar for Forbion Capital Partners
Avatar for TVM Capital
+1

Investors of bluebird bio

ABN AMRO
VC Firm
Avatar for ABN AMRO
RA Capital Management, L.P.
VC Firm • Boston
Avatar for RA Capital Management, L.P.
Invests in life-sciences and drug development companies
Amit Patel
Angel Investor
Avatar for Amit Patel
Founder @Primetime Proprietary Trading #UPENN #MIT: BiBB w/Neuroscience, Philosophy. Securities Trader/Biopharma Analyst/Neuroscientist
Ramius Advisors
VC Firm • New York City
Avatar for Ramius Advisors
Rounds
D
Deerfield Partners
VC Firm • San Francisco
Avatar for Deerfield Partners
Rounds
D
Genzyme Ventures
VC Firm • Cambridge
Avatar for Genzyme Ventures
Rounds
B
ARCH Venture Partners
VC Firm • Austin
Avatar for ARCH Venture Partners
Rounds
D
U
Third Rock Ventures
VC Firm • Boston
Avatar for Third Rock Ventures
Funds and builds life science companies with high growth potential
Rounds
D
U
B
Easton Capital
VC Firm
Rounds
U
B
Log in or sign up to view more investors
Back to Culture and benefits
Onwards to Jobs